The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest pact as part of its “Most Favored Nation” pricing initiative.
As prescription drug prices in the US continue to rise, political leaders across administrations, including recently US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback